The androgen receptor (AR) is active in the majority of prostate tumors which enabled the generation of adenoviral mutants with replication controlled by AR response elements (AREs) to prevent replication in non-prostate tissue [4]. The gene discussed is AR; the disease is prostate neoplasm.